tetano
Editor, Senior Moderator
Respir Med
. 2021 Oct 5;189:106640.
doi: 10.1016/j.rmed.2021.106640. Online ahead of print.
COPD is a risk factor for COVID-19, but does not confer increased severity of the disease
Jae Seok Jeong[SUP] 1 [/SUP], Jong Seung Kim[SUP] 2 [/SUP], Yeon Seok You[SUP] 3 [/SUP], Sang Woo Yeom[SUP] 4 [/SUP], Yong Chul Lee[SUP] 5 [/SUP]
Affiliations
Abstract
Epidemiologic studies suggest that COPD is associated with an increased risk of poor outcome in patients with COVID-19, although they failed to demonstrate COPD as a risk factor for acquiring COVID-19. However, most data have come from a limited global population. In this nationwide cohort study based on the Korean national health insurance claims-based database, COPD is associated with increased risk for COVID-19 and having COPD does not seem to confer substantial risk for severe COVID-19 and mortality. These findings indicate that heterogeneity in the populations across many countries may complicate the net effects of COPD on the COVID-19-related outcomes.
Keywords: COPD; COVID-19; National health insurance service; Severe acute respiratory syndrome coronavirus 2.
. 2021 Oct 5;189:106640.
doi: 10.1016/j.rmed.2021.106640. Online ahead of print.
COPD is a risk factor for COVID-19, but does not confer increased severity of the disease
Jae Seok Jeong[SUP] 1 [/SUP], Jong Seung Kim[SUP] 2 [/SUP], Yeon Seok You[SUP] 3 [/SUP], Sang Woo Yeom[SUP] 4 [/SUP], Yong Chul Lee[SUP] 5 [/SUP]
Affiliations
- PMID: 34627008
- PMCID: PMC8492002
- DOI: 10.1016/j.rmed.2021.106640
Abstract
Epidemiologic studies suggest that COPD is associated with an increased risk of poor outcome in patients with COVID-19, although they failed to demonstrate COPD as a risk factor for acquiring COVID-19. However, most data have come from a limited global population. In this nationwide cohort study based on the Korean national health insurance claims-based database, COPD is associated with increased risk for COVID-19 and having COPD does not seem to confer substantial risk for severe COVID-19 and mortality. These findings indicate that heterogeneity in the populations across many countries may complicate the net effects of COPD on the COVID-19-related outcomes.
Keywords: COPD; COVID-19; National health insurance service; Severe acute respiratory syndrome coronavirus 2.